← Leaderboards
William Robb Maclellan
University Of California Los Angeles
$8,628,494
Attributed
$8,628,494
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $818.4K · FY2005–20$1M$750K$500K$250K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
Funding mix
By agency
NIH$8,628,494 · 6
By mechanism
R01$5,862,377 · 2
P01$2,256,217 · 2
R21$423,500 · 1
K08$86,400 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of California Los Angeles
Same institution · by research overlap
- Samson A Chow$4,913,033
- Reid C Johnson$11,352,177
- Ian Alfredo Mendez$644,305
- Harold M Hoffman$13,923,489
- Earl E Homsher$1,887,200
Others in their field
Top investigators on “Cardiac Myocytes”
- Joseph C Wu · Stanford University$53,447,011
- Donald M Bers · Cincinnati Childrens Hosp Med Ctr$50,074,770
- Jeffery D Molkentin · Cincinnati Childrens Hosp Med Ctr$40,971,477
- Piero Anversa · New York Medical College$40,584,258
- Junichi Sadoshima · Rutgers Biomedical And Health Sciences$34,907,735
- Steven R Houser · Johns Hopkins University$33,565,081
Research focus
Cardiac MyocytesMyocardiumCellsCardiacGrowthCell CycleGenesIn VivoHeartTranscription FactorMuscle CellsFamily MemberResponsePathway InteractionsMediatingInjuryPreventProteinsGene ExpressionMyocardialOverexpressionAdultComplexEpigenetic Process
Grant awards (25)
Genetic Analysis of Cardiac Growth$441,250
R01 · FY2020 · HL · contact PI
Genetic Analysis of Cardiac Growth$440,521
R01 · FY2019 · HL · contact PI
Genetic Analysis of Cardiac Growth$440,000
R01 · FY2018 · HL · contact PI
Genetic Analysis of Cardiac Growth$438,542
R01 · FY2017 · HL · contact PI
Genetic Analysis of Cardiac Growth$378,525
R01 · FY2014 · HL · contact PI
Translational Model of Cell-Based Therapy of r Myocardial Infarction$293,833
P01 · FY2014 · HL · contact PI
Genetic Analysis of Cardiac Growth$367,710
R01 · FY2013 · HL · contact PI
Genetic Analysis of Cardiac Growth$386,250
R01 · FY2012 · HL · contact PI
Genetic Analysis of Cardiac Growth$385,000
R01 · FY2011 · HL · contact PI
Cardiovascular and Therapeutic Potential of Reprogrammed Human Fibroblasts$192,500
R21 · FY2010 · HL · contact PI
ROLE OF CDK2 CELL CYCLE SIGNALING IN ISCHEMIC INJURY AND PROTECTION$417,871
P01 · FY2009 · HL · contact PI
Cardiovascular and Therapeutic Potential of Reprogrammed Human Fibroblasts$231,000
R21 · FY2009 · HL · contact PI
ROLE OF CDK2 CELL CYCLE SIGNALING IN ISCHEMIC INJURY AND PROTECTION$399,173
P01 · FY2008 · HL · contact PI
Genetic Dissection of Cardiac Growth: The Role of c-Myc$422,854
R01 · FY2007 · HL · contact PI
ROLE OF CDK2 CELL CYCLE SIGNALING IN ISCHEMIC INJURY AND PROTECTION$395,535
P01 · FY2007 · HL · contact PI
Genetic Dissection of Cardiac Growth: The Role of c-Myc$422,797
R01 · FY2006 · HL · contact PI
ROLE OF CDK2 CELL CYCLE SIGNALING IN ISCHEMIC INJURY AND PROTECTION$376,288
P01 · FY2006 · HL · contact PI
Genetic Dissection of Cardiac Growth: The Role of c-Myc$419,682
R01 · FY2005 · HL
ROLE OF CDK2 CELL CYCLE SIGNALING IN ISCHEMIC INJURY AND PROTECTION$373,517
P01 · FY2005 · HL
Genetic Dissection of Cardiac Growth: The Role of c-Myc$414,817
R01 · FY2004 · HL
GENETIC ANALYSIS OF CARDIAC TERMINAL DIFFERENTIATION$229,500
R01 · FY2003 · HL
GENETIC ANALYSIS OF CARDIAC TERMINAL DIFFERENTIATION$229,500
R01 · FY2002 · HL
GENETIC ANALYSIS OF CARDIAC TERMINAL DIFFERENTIATION$229,500
R01 · FY2001 · HL
GENETIC ANALYSIS OF CARDIAC TERMINAL DIFFERENTIATION$215,929
R01 · FY2000 · HL
MOLECULAR MECHANISMS OF CARDIAC DIFFERENTIATION$86,400
K08 · FY2000 · HL